UK's NICE Recommends Use of Genomic Health's OncoType DX in Draft Guidance | GenomeWeb

NEW YORK (GenomeWeb News) – The UK's National Institute for Health and Clinical Evidence yesterday issued a draft guidance recommending the use of Genomic Health's OncoType DX in certain early-stage breast cancer patients to help guide chemotherapy decisions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.